# MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
Canonical URL: https://biopharmsignal.com/news/MGNX/macrogenics-reports-third-quarter-2025-financial-results-and-provides-update-on-corporate-progress
Ticker: MGNX
Company: MacroGenics
Source: MacroGenics
Published: 2025-11-12 21:01 EST
Original Source URL: https://ir.macrogenics.com
## Summary

Achieved additional $75 million in partnering proceeds from Sanofi and Gilead Granted license to additional preclinical program to Gilead that leverages MacroGenics’ novel T-cell engager platform Realigned pipeline priorities by ending development of lorigerlimab in prostate cancer while continuing

## Article Body
Achieved additional $75 million in partnering proceeds from Sanofi and Gilead Granted license to additional preclinical program to Gilead that leverages MacroGenics’ novel T-cell engager platform Realigned pipeline priorities by ending development of lorigerlimab in prostate cancer while continuing
## Recent Company News
- 2026-05-14 20:01 EST — [MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum](https://biopharmsignal.com/news/MGNX/macrogenics-to-participate-in-the-stifel-2026-virtual-targeted-oncology-forum) — Source: MacroGenics
- 2026-05-13 20:01 EST — [MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation](https://biopharmsignal.com/news/MGNX/macrogenics-reports-first-quarter-2026-financial-results-and-highlights-business-transformation) — Source: MacroGenics
- 2026-05-11 21:20 EST — [MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals](https://biopharmsignal.com/news/MGNX/macrogenics-to-sell-gmp-manufacturing-operations-to-bora-pharmaceuticals) — Source: MacroGenics
- 2026-05-04 11:30 EST — [MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement](https://biopharmsignal.com/news/MGNX/macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyzr-royalty-purchase-agreement) — Source: MacroGenics
- 2026-04-08 20:30 EST — [FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study](https://biopharmsignal.com/news/MGNX/fda-removes-partial-clinical-hold-on-macrogenics-linnet-study) — Source: MacroGenics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)